The immune system uses different strategies to combat viral and bacterial infections due to the distinct nature of these pathogens.
Bacterial Infections:
Trigger an innate immune response first, involving phagocytes like neutrophils and macrophages.
These cells recognize common bacterial markers (like lipopolysaccharides) and engulf the bacteria.
This leads to inflammation, redness, and pus formation.
The adaptive immune response is activated next, especially B-cells, which produce antibodies that neutralize bacteria or mark them for destruction.
Complement proteins also help lyse bacterial cells.
Viral Infections:
The immune system reacts more subtly, as viruses hide inside host cells.
Interferons (produced by infected cells) signal neighboring cells to enter an antiviral state.
Natural Killer (NK) cells destroy virus-infected cells early on.
Cytotoxic T lymphocytes (CD8+ T cells) play a major role by detecting and killing infected cells.
B-cells also produce antibodies that bind to free virus particles, preventing them from entering new cells.
In both cases, memory cells are generated, offering faster and stronger responses if re-infection occurs.
Vaccination takes advantage of this by introducing harmless viral or bacterial components to stimulate immunity.
Key distinctions:
Bacterial infections usually stimulate antibody-mediated responses (humoral immunity).
Viral infections often require cell-mediated immunity to destroy infected cells.
Understanding these immune responses helps in designing targeted therapies and vaccines. For instance, vaccines for viruses often focus on stimulating T-cell responses, while bacterial vaccines may target surface proteins to elicit antibodies.